about
SIGIRR, a negative regulator of Toll-like receptor-interleukin 1 receptor signalingUpregulation of the let-7 microRNA with precocious development in lin-12/Notch hypermorphic Caenorhabditis elegans mutantsProtein tyrosine kinase regulation by ubiquitination: critical roles of Cbl-family ubiquitin ligasesMutant Cbl proteins as oncogenic drivers in myeloproliferative disordersA comprehensive, multi-scale dynamical model of ErbB receptor signal transduction in human mammary epithelial cellsDistinct effects of EGFR ligands on human mammary epithelial cell differentiationAcquisition of CD80 (B7-1) by T cells.Renal thrombotic microangiopathy in mice with combined deletion of endocytic recycling regulators EHD3 and EHD4.EHD4 and CDH23 are interacting partners in cochlear hair cells.Distinct roles for Rho versus Rac/Cdc42 GTPases downstream of Vav2 in regulating mammary epithelial acinar architecture.Altered thymic positive selection and intracellular signals in Cbl-deficient miceTonic ubiquitylation controls T-cell receptor:CD3 complex expression during T-cell developmentA positive regulatory role for Cbl family proteins in tumor necrosis factor-related activation-induced cytokine (trance) and CD40L-mediated Akt activation.Negative regulation of EGFR-Vav2 signaling axis by Cbl ubiquitin ligase controls EGF receptor-mediated epithelial cell adherens junction dynamics and cell migration.The role of Sox9 in mouse mammary gland development and maintenance of mammary stem and luminal progenitor cellsIndispensable roles of mammalian Cbl family proteins as negative regulators of protein tyrosine kinase signaling: Insights from in vivo modelsContinuous requirement of ErbB2 kinase activity for loss of cell polarity and lumen formation in a novel ErbB2/Neu-driven murine cell line model of metastatic breast cancer.A quinoxaline urea analog uncouples inflammatory and pro-survival functions of IKKβCasitas B-cell lymphoma (Cbl) proteins protect mammary epithelial cells from proteotoxicity of active c-Src accumulation.Binding of Cbl to a phospholipase Cgamma1-docking site on platelet-derived growth factor receptor beta provides a dual mechanism of negative regulation.Cbl-b regulates the CD28 dependence of T-cell activation.Therapeutic potential of chimeric and murine anti-(epidermal growth factor receptor) antibodies in a metastasis model for human melanoma.High c-Kit expression identifies hematopoietic stem cells with impaired self-renewal and megakaryocytic bias.Molecular mechanisms underlying differential contribution of CD28 versus non-CD28 costimulatory molecules to IL-2 promoter activation.Interleukin-2 receptor-inducing factor(s) in adult T cell leukemia.TM1 and TM2: two mutant alleles that constitute a genetic trait controlling thymocyte developmentMechanisms of cellular cytotoxicity mediated by a recombinant antibody-IL2 fusion protein against human melanoma cellsCytokine response gene 8 (CR8) regulates the cell cycle G1-S phase transition and promotes cellular survivalIntraocular in vivo imaging of activated T-lymphocytes expressing green-fluorescent protein after stimulation with endotoxinMice with a fluorescent marker for interleukin 2 gene activationEstablishment of the major compatibility complex-dependent development of CD4+ and CD8+ T cells by the Cbl family proteinsTM1 and TM2: two mutant alleles that are involved in the pre-TCR/TCR signaling
P50
Q24316441-93758702-9439-4C94-B473-8EC8CB505A05Q24652552-CAF7EFB1-317E-4B89-AF01-6791CC9D5EFFQ26852269-1F83AB82-FDE9-4C40-9346-3F92383CAEAEQ28307750-4C92BBD9-6C04-404A-BB7E-EBF280B36D40Q28486292-B77BA94E-56E9-4359-8B52-E238835D032FQ28534115-27D36E88-8218-4C0B-88E0-B3989760BB9AQ31839073-90991EEA-D71C-48FF-914F-B5EA32E3AC64Q33394519-EB55F25C-EE53-42A1-BBCE-B79977650B2FQ33457933-1C1B0CC8-845A-45BF-AB0A-D4438FC5C52CQ33569818-856308A1-5681-4719-B88E-8F11194EFD03Q33596728-EAB19042-A823-407B-9065-70E0AF57B05BQ33801454-33E2ABC7-9326-4558-B9FA-9DDB81286046Q33951432-AC053042-CD59-480F-A468-EC78D414593FQ34452683-436AC9DE-CA14-4246-B773-5F2941ECDAEFQ34978975-3691C32A-03B1-414A-9135-2F21094F21E4Q35015130-6A6BA850-8684-452C-A2E1-3B97C9AD0A2FQ35624809-8F66CE01-B8F5-4080-A9CA-F3E679C0AC3CQ36395993-5546A8D0-F6ED-42ED-969E-E4897F74ABB6Q37534392-BD263A18-254A-4CDC-9355-03EFE3603249Q40109529-F0E1E0CF-DE36-4F9A-8798-F5099BC26428Q40904107-2C468C0E-9757-4DE7-B0CF-F3E4A44FC757Q41522434-4AA8761A-C5DF-4604-9DED-6FC0C5D7BB4AQ41945143-0EB2321D-63B2-438E-B0B1-A765AF91D9C4Q43950664-631EC955-31BB-407E-B66E-30F423623E27Q55243371-664A4016-C196-4498-92C5-3EC255A4C5ADQ62555255-76682321-1346-4A4D-9857-287451C32B01Q72331223-682A2437-1950-4176-A702-E52F0FFC3AF5Q73787314-E501C5BE-CD09-4FD9-9038-6B59BAF8C3C2Q74590263-777CEE8E-F750-4637-A939-D23444F43BCFQ77206870-6F895F59-F486-41F9-80EF-ADFE6711D25AQ79257173-99EFFFD5-3F15-445F-B627-8221573E1AC7Q81026508-CD7BC1A7-F0B0-458B-9833-043AC3B335CA
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Mayumi Naramura
@ast
Mayumi Naramura
@en
Mayumi Naramura
@es
Mayumi Naramura
@nl
type
label
Mayumi Naramura
@ast
Mayumi Naramura
@en
Mayumi Naramura
@es
Mayumi Naramura
@nl
prefLabel
Mayumi Naramura
@ast
Mayumi Naramura
@en
Mayumi Naramura
@es
Mayumi Naramura
@nl
P106
P31
P496
0000-0003-3658-0767